Trials / Completed
CompletedNCT03395496
Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Istanbul University · Academic / Other
- Sex
- All
- Age
- 7 Years – 15 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to compare two pulpotomy medicaments in primary molars clinically.A total of 200 primary molars with deep caries were treated with two different pulpotomy medicaments (Mineral Trioxide Aggregate and BiodentineTM) in this study. The inclusion criteria for tooth selection were no clinical and radiographic evidence of pulp pathology. During 36 months of follow-up at 3-month intervals, clinical and radiographic success and failures were recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Biodentine | Biodentine pulpotomy agent |
| DRUG | ProRoot (Aggregate) | ProRoot MTA pulpotomy agent |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-30
- First posted
- 2018-01-10
- Last updated
- 2018-01-10
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03395496. Inclusion in this directory is not an endorsement.